305 research outputs found
Influence of wall thickness and diameter on arterial shear wave elastography: a phantom and finite element study
Quantitative, non-invasive and local measurements of arterial mechanical
properties could be highly beneficial for early diagnosis of cardiovascular
disease and follow up of treatment. Arterial shear wave elastography (SWE)
and wave velocity dispersion analysis have previously been applied to
measure arterial stiffness. Arterial wall thickness (h) and inner diameter (D)
vary with age and pathology and may influence the shear wave propagation.
Nevertheless, the effect of arterial geometry in SWE has not yet been
systematically investigated. In this study the influence of geometry on the
estimated mechanical properties of plates (h = 0.5â3 mm) and hollow
cylinders (h = 1, 2 and 3 mm, D = 6 mm) was assessed by experiments in
phantoms and by finite element method simulations. In addition, simulations
in hollow cylinders with wall thickness difficult to achieve in phantoms
were performed (h = 0.5â1.3 mm, D = 5â8 mm). The phase velocity curves obtained from experiments and simulations were compared in the frequency
range 200â1000 Hz and showed good agreement (R2 = 0.80 ± 0.07 for plates
and R2 = 0.82 ± 0.04 for hollow cylinders). Wall thickness had a larger effect
than diameter on the dispersion curves, which did not have major effects above
400 Hz. An underestimation of 0.1â0.2 mm in wall thickness introduces an
error 4â9 kPa in hollow cylinders with shear modulus of 21â26 kPa. Therefore,
wall thickness should correctly be measured in arterial SWE applications for
accurate mechanical properties estimation
Method for Ultrasound Vibrometry Using Orthogonal Basis Functions
A method for measuring a mechanical property of a subject includes using an ultrasound transducer to apply ultrasonic vibration pulses to a location in a subject in order to induce shear waves at multiple prescribed orthogonal frequencies in the subject. The ultrasound transducer is directed by an excitation signal that is composed of multiple orthogonal basis functions, each having a given frequency component corresponding to the prescribed orthogonal frequencies. The power level of each orthogonal basis function is independently adjustable. The excitation signal can be sparsely sampled, or portions of the excitation signal can be removed in order to improve tissue vibration and to provide for the interleaving ultrasonic vibration and detection pulses. Ultrasonic detection pulses are applied to at least one motion detection point, from which echo signals are received. From the received echo signals, a motion signal is determined, from which mechanical properties of the subject are calculated.
Patent No.: US 8,602,994
Date of Patent: Dec 20, 2013
Filed: Mar 9, 2010
Int. Cl.: A61B 8/00 (2006.01); G01H 1/00 (2006.01)
U.S. Cl.: 600/438; 73/579
CPC Cl.: G01S 7/52022 (2013.01); A61B 8/485 (2013.01); G01S 15/8952 (2013.01); G01S 7/52036 (2013.01)
Field of Search: ;600/437,443 ;702/19,22 ;382/260 ;345/441,501,552 ;73/574,579,587,60
Breast vibro-acoustography: initial results show promise
INTRODUCTION: Vibro-acoustography (VA) is a recently developed imaging modality that is sensitive to the dynamic characteristics of tissue. It detects low-frequency harmonic vibrations in tissue that are induced by the radiation force of ultrasound. Here, we have investigated applications of VA for in vivo breast imaging. METHODS: A recently developed combined mammography-VA system for in vivo breast imaging was tested on female volunteers, aged 25 years or older, with suspected breast lesions on their clinical examination. After mammography, a set of VA scans was acquired by the experimental device. In a masked assessment, VA images were evaluated independently by 3 reviewers who identified mass lesions and calcifications. The diagnostic accuracy of this imaging method was determined by comparing the reviewers' responses with clinical data. RESULTS: We collected images from 57 participants: 7 were used for training and 48 for evaluation of diagnostic accuracy (images from 2 participants were excluded because of unexpected imaging artifacts). In total, 16 malignant and 32 benign lesions were examined. Specificity for diagnostic accuracy was 94% or higher for all 3 reviewers, but sensitivity varied (69% to 100%). All reviewers were able to detect 97% of masses, but sensitivity for detection of calcification was lower (†72% for all reviewers). CONCLUSIONS: VA can be used to detect various breast abnormalities, including calcifications and benign and malignant masses, with relatively high specificity. VA technology may lead to a new clinical tool for breast imaging applications
Constraint solving in non-permutative nominal abstract syntax
Nominal abstract syntax is a popular first-order technique for encoding, and
reasoning about, abstract syntax involving binders. Many of its applications
involve constraint solving. The most commonly used constraint solving algorithm
over nominal abstract syntax is the Urban-Pitts-Gabbay nominal unification
algorithm, which is well-behaved, has a well-developed theory and is applicable
in many cases. However, certain problems require a constraint solver which
respects the equivariance property of nominal logic, such as Cheney's
equivariant unification algorithm. This is more powerful but is more
complicated and computationally hard. In this paper we present a novel
algorithm for solving constraints over a simple variant of nominal abstract
syntax which we call non-permutative. This constraint problem has similar
complexity to equivariant unification but without many of the additional
complications of the equivariant unification term language. We prove our
algorithm correct, paying particular attention to issues of termination, and
present an explicit translation of name-name equivariant unification problems
into non-permutative constraints
Parameterization Effects in the analysis of AMI Sunyaev-Zel'dovich Observations
Most Sunyaev--Zel'dovich (SZ) and X-ray analyses of galaxy clusters try to
constrain the cluster total mass and/or gas mass using parameterised models and
assumptions of spherical symmetry and hydrostatic equilibrium. By numerically
exploring the probability distributions of the cluster parameters given the
simulated interferometric SZ data in the context of Bayesian methods, and
assuming a beta-model for the electron number density we investigate the
capability of this model and analysis to return the simulated cluster input
quantities via three rameterisations. In parameterisation I we assume that the
T is an input parameter. We find that parameterisation I can hardly constrain
the cluster parameters. We then investigate parameterisations II and III in
which fg(r200) replaces temperature as a main variable. In parameterisation II
we relate M_T(r200) and T assuming hydrostatic equilibrium. We find that
parameterisation II can constrain the cluster physical parameters but the
temperature estimate is biased low. In parameterisation III, the virial theorem
replaces the hydrostatic equilibrium assumption. We find that parameterisation
III results in unbiased estimates of the cluster properties. We generate a
second simulated cluster using a generalised NFW (GNFW) pressure profile and
analyse it with an entropy based model to take into account the temperature
gradient in our analysis and improve the cluster gas density distribution. This
model also constrains the cluster physical parameters and the results show a
radial decline in the gas temperature as expected. The mean cluster total mass
estimates are also within 1 sigma from the simulated cluster true values.
However, we find that for at least interferometric SZ analysis in practice at
the present time, there is no differences in the AMI visibilities between the
two models. This may of course change as the instruments improve.Comment: 19 pages, 13 tables, 24 figure
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
We investigated â„ grade 3 (CTC-AE) organ toxicities for commercial CD19 chimeric antigen receptor T cell (CAR-T cell) products in 492 patients (Axi-Cel; n = 315; Tisa-Cel; n = 177) with Large B-cell Lymphoma in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T registry. The incidence of â„ grade 3 organ toxicities during the first 100 days after CAR-T was low and the most frequent were: renal (3.0%), cardiac (2.3%), gastro-intestinal (2.3%) and hepatic (1.8%). The majority occurred within three weeks after CAR-T cell therapy. Overall survival was 83.1% [79.8-86.5; 95% CI] at 3 months and 53.5% [49-58.4; 95% CI] at one year after CAR-T. The most frequent cause of death was tumour progression (85.1%). Non-relapse mortality was 3.1% [2.3-4.1; 95% CI] at 3 months and 5.2% [4.1-6.5; 95% CI] at one year after CAR-T. The most frequent causes of non-relapse mortality were cell-therapy-related toxicities including organ toxicities (6.4% of total deaths) and infections (4.4% of total deaths). Our data demonstrates good safety in the European real-world setting
EPHRINB2 Knockdown in Cervical Spinal Cord Preserves Diaphragm Innervation in a Mutant SOD1 Mouse Model of ALS
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron loss. Importantly, non-neuronal cell types such as astrocytes also play significant roles in disease pathogenesis. However, mechanisms of astrocyte contribution to ALS remain incompletely understood. Astrocyte involvement suggests that transcellular signaling may play a role in disease. We examined contribution of transmembrane signaling molecule ephrinB2 to ALS pathogenesis, in particular its role in driving motor neuron damage by spinal cord astrocytes. In symptomatic SOD1G93A mice (a well-established ALS model), ephrinB2 expression was dramatically increased in ventral horn astrocytes. Reducing ephrinB2 in the cervical spinal cord ventral horn via viral-mediated shRNA delivery reduced motor neuron loss and preserved respiratory function by maintaining phrenic motor neuron innervation of diaphragm. EphrinB2 expression was also elevated in human ALS spinal cord. These findings implicate ephrinB2 upregulation as both a transcellular signaling mechanism in mutant SOD1-associated ALS and a promising therapeutic target
- âŠ